AmerisourceBergen
Market Cap
US$22.1b
Last Updated
2021/01/25 23:05 UTC
Data Sources
Company Financials +
Executive Summary
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential average dividend payer.
Similar Companies
Share Price & News
How has AmerisourceBergen's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ABC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ABC's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
0.07%
ABC
-0.3%
US Healthcare
2.3%
US Market
1 Year Return
22.1%
ABC
16.2%
US Healthcare
23.8%
US Market
Return vs Industry: ABC exceeded the US Healthcare industry which returned 16.2% over the past year.
Return vs Market: ABC underperformed the US Market which returned 23.8% over the past year.
Shareholder returns
| ABC | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.07% | -0.3% | 2.3% |
| 30 Day | 10.2% | 5.0% | 4.8% |
| 90 Day | 9.4% | 12.9% | 16.7% |
| 1 Year | 24.3%22.1% | 17.6%16.2% | 26.6%23.8% |
| 3 Year | 7.3%1.7% | 29.1%23.6% | 45.0%35.4% |
| 5 Year | 31.2%20.1% | 93.3%79.1% | 126.2%101.0% |
Long-Term Price Volatility Vs. Market
How volatile is AmerisourceBergen's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
If You Had Bought AmerisourceBergen (NYSE:ABC) Stock A Year Ago, You Could Pocket A 14% Gain Today2 months ago | Simply Wall St
Dividend Investors: Don't Be Too Quick To Buy AmerisourceBergen Corporation (NYSE:ABC) For Its Upcoming Dividend3 months ago | Simply Wall St
Is AmerisourceBergen (NYSE:ABC) Using Too Much Debt?Valuation
Is AmerisourceBergen undervalued compared to its fair value and its price relative to the market?
44.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ABC ($107.76) is trading below our estimate of fair value ($192.25)
Significantly Below Fair Value: ABC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ABC is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: ABC is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ABC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ABC has negative assets, so we can't compare its PB Ratio to the US Healthcare industry average.
Next Steps
Future Growth
How is AmerisourceBergen forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
49.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: ABC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ABC's is expected to become profitable in the next 3 years.
Revenue vs Market: ABC's revenue (5.2% per year) is forecast to grow slower than the US market (10.6% per year).
High Growth Revenue: ABC's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ABC's Return on Equity is forecast to be very high in 3 years time (94.7%).
Next Steps
Past Performance
How has AmerisourceBergen performed over the past 5 years?
-13.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ABC is currently unprofitable.
Growing Profit Margin: ABC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ABC is unprofitable, and losses have increased over the past 5 years at a rate of 13.8% per year.
Accelerating Growth: Unable to compare ABC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ABC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (20.7%).
Return on Equity
High ROE: ABC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Next Steps
Financial Health
How is AmerisourceBergen's financial position?
Financial Position Analysis
Short Term Liabilities: ABC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ABC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ABC has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ABC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: ABC's debt is well covered by operating cash flow (53.6%).
Interest Coverage: ABC is unprofitable, therefore interest payments are not well covered by earnings.
Balance Sheet
Next Steps
Dividend
What is AmerisourceBergen current dividend yield, its reliability and sustainability?
1.65%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ABC's dividend (1.63%) is higher than the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: ABC's dividend (1.63%) is low compared to the top 25% of dividend payers in the US market (3.86%).
Stability and Growth of Payments
Stable Dividend: ABC's dividends per share have been stable in the past 10 years.
Growing Dividend: ABC's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: ABC is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: ABC's dividends in 3 years are forecast to be well covered by earnings (18.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.9yrs
Average management tenure
CEO
Steve Collis (59 yo)
9.5yrs
Tenure
US$11,309,930
Compensation
Mr. Steven H. Collis, also known as Steve, has been the Chief Executive Officer and President of AmerisourceBergen Corporation since July 2011 and November 2010. Previously, Mr. Collis served as the Chief ...
CEO Compensation Analysis
Compensation vs Market: Steve's total compensation ($USD11.31M) is about average for companies of similar size in the US market ($USD10.57M).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 9.5yrs | US$11.31m | 0.055% $ 12.1m | |
| Executive VP & CFO | 2.17yrs | US$3.45m | 0.0024% $ 525.0k | |
| Executive VP and Chief Communications & Administration Officer | 3.58yrs | US$2.37m | 0.0055% $ 1.2m | |
| Executive VP & Chief Legal Officer | 3.58yrs | US$3.51m | 0.021% $ 4.7m | |
| Executive VP & Group President | 5.92yrs | US$3.54m | 0.011% $ 2.3m | |
| Senior VP | 6.08yrs | no data | 0.0072% $ 1.6m | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Executive VP & Chief Compliance Officer | 2.25yrs | no data | 0.0034% $ 743.3k | |
| Executive VP & Chief Human Resources Officer | 2yrs | no data | 0.00019% $ 41.9k | |
| Executive VP & Chief Strategy Officer | 1.5yrs | no data | 0.000030% $ 6.6k | |
| Senior VP and Chief Diversity & Inclusion Officer | 0.17yr | no data | no data | |
| VP & Corporate Treasurer | no data | no data | no data |
2.9yrs
Average Tenure
57yo
Average Age
Experienced Management: ABC's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 9.5yrs | US$11.31m | 0.055% $ 12.1m | |
| Independent Director | 12.33yrs | US$295.07k | 0.0069% $ 1.5m | |
| Independent Director | 14.67yrs | US$300.07k | 0.0060% $ 1.3m | |
| Independent Director | 5.33yrs | US$281.32k | 0.0038% $ 831.6k | |
| Independent Director | 7.67yrs | US$298.75k | 0.0061% $ 1.3m | |
| Independent Director | 10.67yrs | US$281.32k | 0.0060% $ 1.3m | |
| Lead Independent Director | 4.83yrs | US$332.58k | 0.0090% $ 2.0m | |
| Independent Director | 1yr | no data | 0.00027% $ 59.6k | |
| Director | 6yrs | no data | no data | |
| Independent Director | 16.17yrs | US$305.95k | 0.0082% $ 1.8m |
6.8yrs
Average Tenure
67yo
Average Age
Experienced Board: ABC's board of directors are considered experienced (6.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
AmerisourceBergen Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: AmerisourceBergen Corporation
- Ticker: ABC
- Exchange: NYSE
- Founded: 1985
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$22.058b
- Shares outstanding: 204.69m
- Website: https://www.amerisourcebergen.com
Number of Employees
Location
- AmerisourceBergen Corporation
- 1300 Morris Drive
- Chesterbrook
- Pennsylvania
- 19087-5594
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ABC | NYSE (New York Stock Exchange) | Yes | Common Shares | US | USD | Apr 1995 |
| ABG | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Apr 1995 |
| 0HF3 | LSE (London Stock Exchange) | Yes | Common Shares | GB | USD | Apr 1995 |
| A1MB34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 2 REPR 1 COM | BR | BRL | Jan 2020 |
Biography
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceut...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/25 23:05 |
| End of Day Share Price | 2021/01/25 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2020/09/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.